Defence Therapeutics Inc.
DTC
주식 순위
#29780
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
주가
$0.24953854
마지막 동기화: 2026-10-16
시가총액
$18.91M
변동 (1일)
-5.56%
변동 (1년)
-53.23%
국가
CA
거래 Defence Therapeutics Inc. (DTC)
카테고리
Healthcare
의 시가총액 Defence Therapeutics Inc.(DTC)
시가총액: $18.91M
October 2026 기준으로 Defence Therapeutics Inc.의 시가총액은 $18.91M입니다. 이는 당사 데이터에 따르면 Defence Therapeutics Inc.이 세계에서 29780th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2021부터 2026까지 Defence Therapeutics Inc.의 시가총액 기록
